Phase IV Open Label Single Group One Year Study Of Home Self-injection With Sayana (Registered) Press In Adult Women Of Reproductive Age - A Pragmatic Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2017
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Pfizer
- 29 Nov 2017 Planned End Date changed from 22 May 2019 to 14 Dec 2018.
- 29 Nov 2017 Planned primary completion date changed from 22 May 2019 to 14 Dec 2018.
- 07 Sep 2017 Status changed from not yet recruiting to recruiting.